In situ solidifying complex coacervates and methods of making and using thereof
First Claim
1. A method for reducing or inhibiting blood flow in a blood vessel of the subject comprising introducing into the vessel an adhesive fluid complex coacervate comprising at least one polycation, at least one polyanion, and a monovalent salt, wherein the concentration of the monovalent salt selected from the group consisting of NaCl, KCl, and mixtures thereof in the adhesive fluid complex coacervate is greater than the concentration of the monovalent salt in the blood vessel of the subject, whereupon introduction of the adhesive fluid complex coacervate into the vessel the adhesive fluid complex coacervate is converted to a solid in situ that creates an artificial embolus within the vessel.
3 Assignments
0 Petitions
Accused Products
Abstract
Described herein are fluid complex coacervates that produce solid adhesives in situ. Oppositely charged polyelectrolytes were designed to form fluid adhesive complex coacervates at ionic strengths higher than the ionic strength of the application site, but an insoluble adhesive solid or gel at the application site. When the fluid, high ionic strength adhesive complex coacervates are introduced into the lower ionic strength application site, the fluid complex coacervate is converted to a an adhesive solid or gel as the salt concentration in the complex coacervate equilibrates to the application site salt concentration. In one embodiment, the fluid complex coacervates are designed to solidify in situ at physiological ionic strength and have numerous medical applications. In other aspects, the fluid complex coacervates can be used in aqueous environment for non-medical applications.
70 Citations
27 Claims
- 1. A method for reducing or inhibiting blood flow in a blood vessel of the subject comprising introducing into the vessel an adhesive fluid complex coacervate comprising at least one polycation, at least one polyanion, and a monovalent salt, wherein the concentration of the monovalent salt selected from the group consisting of NaCl, KCl, and mixtures thereof in the adhesive fluid complex coacervate is greater than the concentration of the monovalent salt in the blood vessel of the subject, whereupon introduction of the adhesive fluid complex coacervate into the vessel the adhesive fluid complex coacervate is converted to a solid in situ that creates an artificial embolus within the vessel.
-
23. The method of claim 1, wherein the adhesive fluid complex coacervate further comprises a reinforcing component.
-
24. The method of claim 23, wherein the reinforcing component comprises natural or synthetic fibers, water-insoluble filler particles, a nanoparticle, or a microparticle.
-
25. The method of claim 1, wherein the adhesive fluid coacervate further comprises one or more bioactive agents.
-
26. The method of claim 25, wherein the bioactive agent comprises an antibiotic, a pain reliever, an immune modulator, a growth factor, an enzyme inhibitor, a hormone, a mediator, a messenger molecule, a cell signaling molecule, a receptor agonist, an oncolytic, a chemotherapy agent, a receptor antagonist, a nucleic acid, or any combination thereof.
-
27. The method of claim 1, wherein the polycation is a synthetic polyguanidino polymer comprising the polymerization product between a monomer selected from the group consisting of an acrylate, a methacrylate, an acrylamide, a methacrylamide, or any combination thereof and a compound of formula I
Specification